Your browser doesn't support javascript.
loading
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV.
Kennedy, Amy J; McGinnis, Kathleen A; Merlin, Jessica S; Edelman, E Jennifer; Gordon, Adam J; Korthuis, P Todd; Skanderson, Melissa; Williams, Emily C; Wyse, Jessica; Oldfield, Benjamin; Bryant, Kendall; Justice, Amy; Fiellin, David A; Kraemer, Kevin L.
Affiliation
  • Kennedy AJ; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • McGinnis KA; VA Connecticut Healthcare System, West Haven, CT, USA.
  • Merlin JS; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Edelman EJ; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
  • Gordon AJ; Program for Addiction Research, Clinical Care, Knowledge and Advocacy, Division of Epidemiology, Department of Internal Medicine, University of Utah; Informatics, Decision-Enhancement, and Analytic Sciences Center, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.
  • Korthuis PT; Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health and Sciences University, Portland, OR, USA.
  • Skanderson M; VA Connecticut Healthcare System, West Haven, CT, USA.
  • Williams EC; Department of Health Services, University of Washington, VA Puget Sound Healthcare System, Seattle, WA, USA; Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development VA Puget Sound Healthcare System, Seattle, WA, USA.
  • Wyse J; VA Portland Healthcare System, Portland, OR, USA; School of Public Health, Oregon Health and Sciences University, Portland, OR, USA.
  • Oldfield B; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Bryant K; National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
  • Justice A; VA Connecticut Healthcare System, West Haven, CT, USA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Fiellin DA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
  • Kraemer KL; Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA; VA Pittsburgh Healthcare System, Pittsburgh, PA, USA. Electronic address: kraemerkl@upmc.edu.
J Subst Abuse Treat ; 132: 108509, 2022 01.
Article in En | MEDLINE | ID: mdl-34130128
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / HIV Infections / Opioid-Related Disorders Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Subst Abuse Treat Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / HIV Infections / Opioid-Related Disorders Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Subst Abuse Treat Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States